ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs.

March 26, 2004

In Brief: O’Brien Will Leave USC To Become Medical School Dean At Creighton; DRCCA Adds New Staff Members

May 14, 1982

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

Cancer Meetings For May, June, Future

April 27, 1990

Breast Removal Reduces Risk Of Cancer In BRCA Carriers

October 26, 2001

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997